RADx Tech Accurate, Sensitive and Affordable POC Device

The National Institutes of Health intends to award a sole-source contract modification to MicroGEM US Inc. to extend their existing RADx Tech contract for three months. The original scope of work under contract 75N92020C00015 involves producing a non-invasive, portable, saliva-based, high-performing RT-PCR point-of-care test and device for SARS-CoV-2 that provides results in 25 minutes. The modification aims to maintain MicroGEM's production capacity of 160,000 cartridges and 1,000 devices per day to meet increased COVID-19 testing demands due to the Delta variant. Interested parties must submit capability statements through FedConnect by August 23, 2021 demonstrating their ability to fulfill the requirements. The National Heart, Lung, and Blood Institute and National Institute of Biomedical Imaging and Bioengineering will evaluate responses to determine if competition is necessary.

There is no set-aside designation for this opportunity. The NAICS code is 334516 and PSC code is R425. The current contractor is MicroGEM US Inc. under contract 75N92020C00015. The modification aims to maintain MicroGEM's production capacity of 160,000 cartridges and 1,000 devices per day for three months to meet increased COVID-19 testing demands.